BiotechTube
Home/GlyProVac/Jakob Møller-Jensen
JM

Jakob Møller-Jensen

Co-inventor (BEMAP)

GlyProVac

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

GlyProVac Pipeline

DrugIndicationPhase
GPV02Pan-E. coli infections (UTIs, neonatal sepsis, diarrhoea)Pre-clinical

Leadership Team at GlyProVac

AB
Anders Boysen
Founder
AZ
Ann Zahle Andersen
Co-founder
MR
Martin Røssel Larsen
Co-inventor (BEMAP)
GP
Giuseppe Palmisano
Co-inventor (BEMAP)
View full GlyProVac profile